Clinical Trials Browser

Carcinoma, Intraductal, Noninfiltrating × poly ICLC × 1 year × Clear all

NCT06218303 2026-03-12

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

Phase 1 Recruiting

Carcinoma, Intraductal, Noninfiltrating